Scleroderma. 1. Clinical features, course of illness and response to treatment in 61 cases.
D000328:Adult; D000367:Age Factors; D000368:Aged; D062365:Aminobenzoates / Q000627:therapeutic use; D003348:Cortisone / Q000627:therapeutic use; D004492:Edetic Acid / Q000627:therapeutic use; D005260:Female; D049672:History, 19th Century; D049673:History, 20th Century; D006801:Humans; D008297:Male; D008875:Middle Aged; D011188:Potassium / Q000627:therapeutic use; D011379:Prognosis; D011928:Raynaud Disease / Q000175:diagnosis; D012595:Scleroderma, Systemic / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy / Q000266:history / Q000628:therapy*; D012737:Sex Factors; D013562:Sympathectomy
D062365:Aminobenzoates; D004492:Edetic Acid; D011188:Potassium; D003348:Cortisone